N-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)-acetamide

6296-53-3 N-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)-acetamide 99%

Price	Get Latest Price
Packge	1MT	1kg	5kg	10kg	25kg

Min. Order:1MT
Time:2024-02-21

Product Details

Product NameN-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)-acetamide
CAS No.6296-53-3
EINECS No.808-040-8
MFC10H7NO4
MW205.17
InChIKeyPAUAJOABXCGLCN-UHFFFAOYSA-N
AppearanceSolidOff-White to Pale Yellow
Melting point 185-186℃
Boiling point 489.1±28.0 °C(Predicted)
density 1.512±0.06 g/cm3(Predicted)
storage temp. Inert atmosphere,Room Temperature

Company Profile Introduction

Glyra Healthcare Private Limited is a Private company incorporated on 16 January 2018. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 100,000 and its paid up capital is Rs. 100,000. It's NIC code is 519 (which is part of its CIN). As per the NIC code, it is inolved in Other wholesale [Includes specialized wholesale not covered in any one of the previous categories and wholesale in a variety of goods without any particular specialization.].

Glyra Healthcare's Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2023.

Directors of Glyra Healthcare are BHAVESHKUMAR NATHANI RANCHHODBHAI and BHAVISHABEN BHAVESHKUMAR NATHANI.

Glyra Healthcare's Corporate Identification Number (CIN) is U51909GJ2018PTC100558 and its registration number is 100558. Users may contact Glyra Healthcare on its Email address - BHAVESH.NATHANI@GLYRAHEALTHCARE.COM. Registered address of Glyra Healthcare is 1137/1, MELDI ESTATE, NR. MELDI MATA TEMPLE, NR. RAILWAY CROSSING, , Gandhinagar, Gujarat, India - 382481.